01491nam 2200433 450 991070736470332120160715104931.0(CKB)5470000002463870(OCoLC)953619871(OCoLC)995470000002463870(EXLCZ)99547000000246387020160715d1990 ua 0engurmn|||||||||rdacontentrdamediardacarrierPerspectives of drug manufacturers abbreviated new drug applications[Washington, D.C.] :Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections,1990.1 online resource (27 unnumbered pages) illustrationsTitle from title screen (viewed July 14, 2016)."February 1990.""OEI-12-90-00770."Includes bibliographical references (page 15).Perspectives of drug manufacturers Generic drugsUnited StatesPharmaceutical policyUnited StatesDrug approvalUnited StatesPharmaceutical industryUnited StatesGeneric drugsPharmaceutical policyDrug approvalPharmaceutical industryGPOGPOBOOK9910707364703321Perspectives of drug manufacturers3487044UNINA